Correlation between chemotherapy treatments administered and the ChemoID test report predictions
tumor, physician-choice
TUMOR
The drug response to each chemotherapy and their combinations were analyzed to determine the proportion of patients who benefitted from a sensitive vs. non-sensitive chemotherapy chosen prospectively by the ChemoID assay. A pyramid diagram representation of the comparison in percent of cell kill of the most cytotoxic drugs found by the ChemoID assay compared with the actual cell kill percentages of the chemotherapy treatment used for both physician-choice and ChemoID-guided groups for each patient is shown in The distribution of cell kill predicted by the assay for the bulk of the tumor and the CSC assay of the drugs that were used to treat subjects in the physician-choice vs. the ChemoID-guided group is shown in 